Bibliographic information
GuidelineMedical eligibility criteria for contraceptive use
Year of Publication2015
Issuing InstitutionWorld Health Organization
Recommendation
Maintained
Originally developed
Women living with severe or advanced HIV clinical disease (WHO stage 3 or 4) generally should not initiate use of the levonorgestrel-releasing intrauterine device(LNG-IUD) ( until their illness has improved to asymptomatic or mild HIV clinical disease (WHO stage 1 or 2).
Certainty of evidence
Moderate
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
Medical eligibility criteria for contraceptive use, 6th ed.
Year2025
InstitutionWorld Health Organization